InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by James Gamgort. Director active across 1 company, notably IRLAB Therapeutics AB. In total, 4 disclosures have been recorded. Activity tracked since 7 July 2026. The latest transaction was disclosed on 8 July 2026 (Purchase). Regulator: FIN-FSA. The full history is accessible without signup.
4 of 4 declarations
James Gamgort is a declarant linked to IRLAB Therapeutics AB, where he is Styrelseledamot. The record shows 4 filings in total, and across the 4 sampled recent filings between 2026-07-08 and 2026-07-09, the transactions are purchases for EUR 62940, with EUR 0 of sales.